What is the equity of BioArctic this year?
BioArctic has equity of 1.05 B SEK this year.
BioArctic Equity 2024
BioArctic Equity
1.05 B SEK
Ticker
BIOA B.ST
ISIN
SE0010323311
WKN
A2H5GS
In 2024, BioArctic's equity was 1.05 B SEK, a 33.11% increase from the 786.24 M SEK equity in the previous year.
BioArctic Aktienanalyse
What does BioArctic do?
BioArctic AB is a Swedish biotechnology company founded in 2003. The company is based in Stockholm and focuses on the development of innovative therapeutics for nervous system diseases such as Alzheimer's, Parkinson's, and spinal cord injuries. The company uses its expertise in biological and chemical drug research to discover and develop new therapeutic possibilities, with a focus on Amyloid-Beta production. BioArctic's business strategy is based on partnerships with pharmaceutical and biotech companies worldwide, working closely with partners to develop therapies and products that meet the needs and expectations of patients and doctors. BioArctic conducts research in three different areas: Alzheimer's, Parkinson's, and spinal cord injuries. The company works with partners such as Nutricia, Eisai, Just Biotherapeutics, Abcam, Neuropharm, AbbVie, Q-Med, Uppsala University, and the Karolinska Institute to develop treatments for these conditions. BioArctic has already brought several promising products to market, including BAN2401 for Alzheimer's and SC0806 for spinal cord injuries. Overall, BioArctic is a leading company in biological and chemical drug research, with a focus on developing new therapies and products for the benefit of patients and doctors worldwide. BioArctic ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing BioArctic's Equity
BioArctic's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding BioArctic's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating BioArctic's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
BioArctic's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in BioArctic’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about BioArctic stock
What was the equity of BioArctic compared to the previous year?
The equity of BioArctic has increased/decreased by 33.11% increased compared to the previous year.
What impact does a high equity have on investors of BioArctic?
A high equity is advantageous for investors of BioArctic as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of BioArctic?
A low equity can be a risk for investors of BioArctic, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of BioArctic affect the company?
An increase in equity of BioArctic can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of BioArctic affect the company?
A reduction in equity of BioArctic can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of BioArctic?
Some factors that can affect the equity of BioArctic include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of BioArctic so important for investors?
The equity of BioArctic is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can BioArctic take to change the equity?
To change equity, BioArctic can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does BioArctic pay?
Over the past 12 months, BioArctic paid a dividend of 1.5 SEK . This corresponds to a dividend yield of about 0.78 %. For the coming 12 months, BioArctic is expected to pay a dividend of 4.63 SEK.
What is the dividend yield of BioArctic?
The current dividend yield of BioArctic is 0.78 %.
When does BioArctic pay dividends?
BioArctic pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of BioArctic?
BioArctic paid dividends every year for the past 4 years.
What is the dividend of BioArctic?
For the upcoming 12 months, dividends amounting to 4.63 SEK are expected. This corresponds to a dividend yield of 2.4 %.
In which sector is BioArctic located?
BioArctic is assigned to the 'Health' sector.
Wann musste ich die Aktien von BioArctic kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of BioArctic from 5/16/2019 amounting to 1.5 SEK, you needed to have the stock in your portfolio before the ex-date on 5/10/2019.
When did BioArctic pay the last dividend?
The last dividend was paid out on 5/16/2019.
What was the dividend of BioArctic in the year 2023?
In the year 2023, BioArctic distributed 0 SEK as dividends.
In which currency does BioArctic pay out the dividend?
The dividends of BioArctic are distributed in SEK.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von BioArctic
Our stock analysis for BioArctic Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BioArctic Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
